(Q42999098)

12 November 2017

title

Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study (English)

1 reference

12 November 2017

Dutta U

1

1 reference

12 November 2017

Byth K

2

1 reference

12 November 2017

Kench J

3

1 reference

12 November 2017

Khan MH

4

1 reference

12 November 2017

Coverdale SA

5

1 reference

12 November 2017

Weltman M

6

1 reference

12 November 2017

Lin R

7

1 reference

12 November 2017

Liddle C

8

1 reference

12 November 2017

Farrell GC

9

1 reference

12 November 2017

publication date

1 June 1999

1 reference

Australian and New Zealand journal of medicine

12 November 2017

published in

1 reference

12 November 2017

volume

29

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

300-307

1 reference

Hepatitis C: somber views of natural history and optimistic views of interferon treatment?

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Etiology, screening, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Classification of chronic viral hepatitis: a need for reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Therapy of hepatitis C: Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis C genotypes: the key to pathogenicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis C genotypes: current trends and future implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Molecular epidemiology of hepatitis C in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis B virus and hepatocellular carcinoma: molecular biology and mechanistic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

The role of hepatitis B virus in development of primary hepatocellular carcinoma: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

Relationship between hepatocellular carcinoma and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1999.TB00710.X

10.1111/J.1445-5994.1999.TB00710.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference